Selected Engagements

  • 01
    Characterising the new access landscapes for digital health innovation
    Our client was seeking to analysis better understand e-health funding and reimbursement policies and how each country’s current healthcare system support the...
    View engagement
  • 02
    Public affairs toolkit on critical policy issues for gene therapies
    Given the increasing number of government and stakeholder debates and forums around gene therapies, a global pharmaceutical company asked CRA to set out the...
    View engagement
  • 03
    CRA evaluates damages for alleged improper grant of patent sublicense
    CRA provided an expert opinion on damages in breach of contract litigation concerning the alleged improper grant of a patent sublicense. CRA identified the...
    View engagement